CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity [Phase 1]
Summary
A Phase 1 single and multiple ascending dose study of AMG 171 in adults with obesity was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Obesity | Phase 1 | Status: TERMINATED | Results posted: 2024-09-19